Five Prime Therapeutics Inc (FPRX) Jumps 8.72% on January 20

Equities Staff |

Five Prime Therapeutics Inc (FPRX) was among the biggest gainers on the Russell 2000 for Wednesday January 20 as the stock popped 8.72% to $35.17, representing a gain of $2.82 per share. Some 300,823 shares traded hands on 3,634 trades, compared with an average daily volume of 590,990 shares out of a total float of 27.5 million. The stock opened at $32.02 and traded with an intraday range of $35.19 to $30.77.

After today's gains, Five Prime Therapeutics Inc reached a market cap of $967.31 million. Five Prime Therapeutics Inc has had a trading range between $45.72 and $14.70 over the last year, and it had a 50-day SMA of $38.07 and a 200-day SMA of $26.36.

Five Prime Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in discovering & developing novel protein therapeutics to improve lives of patients with serious diseases. Its product include FP-1039/GSK3052230, FPA008 & FPA144.

Five Prime Therapeutics Inc is based out of South San Francisco, CA and has some 124 employees. Its CEO is Lewis T. Williams.

For a complete fundamental analysis analysis of Five Prime Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for FPRX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Enertopia Corp

Enertopia Corp is engaged in the exploration of lithium in Nevada, USA. The Company's project includes Central Nevada Lithium Brine Projects.

Private Markets

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…